The Accurian™ radiofrequency (RF) ablation platform combines proprietary hardware design and quad core processing, resulting in sophisticated algorithms that manage power and control temperature during ablation surgery.

The Accurian™ ablation therapy platform has been extensively tested for lasting reliability and is upgrade-ready for the future.

Launching Soon.

For more information visit Medtronic US: Accurian™


Revolution Surgical Pty Ltd
5/14-16 Crescent Street, Rozelle NSW 2039 AU
ABN: 63 165 643 434

© 2018-2021 Revolution Surgical

Website by: WebInjection